pt20
Resistance thermometers, also called resistance temperature detectors (RTDs), are sensors used to measure temperature. Many RTD elements consist of a length of fine wire wrapped around a heat-resistant ceramic or glass core but other constructions are also used. The RTD wire is a pure material, typically platinum (Pt), nickel (Ni), or copper (Cu). The material has an accurate resistance/temperature relationship which is used to provide an indication of temperature. As RTD elements are fragile, they are often housed in protective probes. RTDs have higher accuracy and repeatability than thermocouples, which is why they are slowly replacing them in industrial applications below 600 °C. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2014 (NCT02151643)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- PhosphateBINDING AGENT
Phosphate binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaResistance thermometer ↗
Also known as
- pt20
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02151643 | Phase 2 | May 1, 2014 | Shield Therapeutics |
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shield Therapeutics | For profit | 1 | 1 | 1 | 2014 |